A stability-indicating high performance liquid chromatographic assay for the determination of orlistat in capsules
- 17 April 2006
- journal article
- research article
- Published by Elsevier in Journal of Chromatography A
- Vol. 1116 (1-2) , 153-157
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- OrlistatDrugs, 2004
- Long-Term Treatment With The Lipase-Inhibiting Agent Orlistat (Xenical® Is Well Tolerated By Obese PatientsJournal of the American Dietetic Association, 1998
- An assessment of the efficacy and safety of orlistat for the long-term management of obesityThe Journal of Nutritional Biochemistry, 1998
- Quantitative liquid chromatographic–tandem mass spectrometric determination of orlistat in plasma with a quadrupole ion trapJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Quantitative Determination of Orlistat(Tetrahydrolipostatin, Ro 18-0647) in HumanPlasma by High-performance LiquidChromatography Coupled with Ion Spray Tandem Mass SpectrometryJournal of Mass Spectrometry, 1997
- Tetrahydrolipstatin: Degradation products produced by human carboxyl‐ester lipaseHelvetica Chimica Acta, 1992
- Tetrahydrolipstatin: Thermal and Hydrolytic DegradationHelvetica Chimica Acta, 1990
- Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. II. Chemistry and structure elucidation.The Journal of Antibiotics, 1987
- Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity.The Journal of Antibiotics, 1987